FOXO Technologies, Inc. (FOXO) - Total Stockholders' Equity

This price chart illustrates the price action of micro-cap biotech FOXO Technologies (FOXO), whose business relies on digital media and AI-driven longevity analysis tools, with the current indicator standing at 0.06. FOXO Technologies (FOXO) is integrating DNA diagnostics into the insurance sector to enable precise risk calculations and individualized premiums. The project is at the start of its expansion, offering the market innovative methods for personalized life expectancy assessment.

This indicator determines the real net asset value, stripping the fundamental valuation of market noise and speculative price fluctuations. By analyzing the organization's balance sheet capitalization, the investor sees the actual business value, which for FOXO Technologies (FOXO) is constrained by a lack of mass demand for its AI platform and a reliance on external grants during the early stages of commercialization.